Austria – Antineoplastic agents – AM_Lieferung eines Lutetium-177-PSMA-Radioligandentherapeutikums

open

Gemeinnützige Salzburger Landeskliniken Betriebsgesellschaft mbH

Read the notice at ted-eu ↗

Value

unstated

Published

6 Oct 2026

Deadline

—

Type

opportunity · framework

33652100 · Medical equipment, pharmaceuticals & personal care33600000 · Medical equipment, pharmaceuticals & personal care

Description

Rahmenvereinbarung mit einem Unternehmen für 36 Monate über die bedarfsgerechte Lieferung eines in der Europäischen zugelassenen Lutetium-177-PSMA-Radioligandentherapeutikums oder eines gleichwertigen Radioligandentherapeutikums gemäß technischem Leistungsverzeichnis für das Universitätsklinikum für Nuklearmedizin und Endokrinologie für die Gemeinnützige Salzburger Landeskliniken Betriebsgesellschaft mbH. Voraussichtlicher Bedarf: 175 Therapiegaben

Key facts

Procedure: neg-w-call
Framework agreement: Yes — a framework or dynamic purchasing system, not a single contract
Submit via: https://salk.vemap.com
Contact: Einkauf-Logistik@salk.at
Framework ceiling: €3.0m
Regime: publicSector
Category: supplies

What a subscription adds to this notice

The documents — every attachment, with its text extracted and searchable
Qualification — the notice scored against your company profile
Tracking and alerts — a pipeline for your bids, and the matching notices by email
The API and MCP — the same record in your own tools and your AI assistant

Start your 7-day free trial Sign in

Provenance

Source: ted-eu
Notice id: 685794-2026
First seen: 9 Oct 2026
Last updated: 9 Oct 2026

Licence EU reuse — Commission Decision 2011/833/EU ↗

View at source ↗GET /api/v1/tenders/0b8389a4-beb8-42b5-b9ce-af5a2b14bc48

The source notice is authoritative — verify deadlines and documents there before bidding.